Literature DB >> 34473242

Association of E484K Spike Protein Mutation With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Vaccinated Persons: Maryland, January-May 2021.

Kenneth A Feder1,2,3, Ami Patel3, Venkata R Vepachedu3, Catherine Dominguez3, Eric N Keller3, Liore Klein3, Curi Kim3, Tim Blood3, Judie Hyun3, Thelonious W Williams3,4, Katherine A Feldman3, Heba H Mostafa5, C Paul Morris5,6, Jacques Ravel7, Monique Duwell3, David Blythe3, Robert Myers3.   

Abstract

Among 9048 people infected with SARS-CoV-2 between January and May 2021 in Maryland, in regression-adjusted analysis, SARS-CoV-2 viruses carrying the spike protein mutation E484K were disproportionately prevalent among persons infected after full vaccination against COVID-19 compared with infected persons who were not fully vaccinated (aOR, 1.96; 95% CI: 1.36-2.83). Published by Oxford University Press for the Infectious Diseases Society of America 2021.

Entities:  

Keywords:  B.1.351; COVID-19; E484K; L452R; genomic surveillance

Mesh：

Substances：

Year:  2022        PMID： 34473242      PMCID： PMC8522365          DOI： 10.1093/cid/ciab762

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  4 in total

1.  COVID-19 Variant Detection with a High-Fidelity CRISPR-Cas12 Enzyme.

Authors:  Clare L Fasching; Venice Servellita; Bridget McKay; Vaishnavi Nagesh; James P Broughton; Alicia Sotomayor-Gonzalez; Baolin Wang; Noah Brazer; Kevin Reyes; Jessica Streithorst; Rachel N Deraney; Emma Stanfield; Carley G Hendriks; Becky Fung; Steve Miller; Jesus Ching; Janice S Chen; Charles Y Chiu
Journal:  J Clin Microbiol       Date:  2022-06-29       Impact factor: 11.677

2.  SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis.

Authors:  Ibrahim Khater; Aaya Nassar
Journal:  Inform Med Unlocked       Date:  2022-02-04

3.  Large Scale SARS-CoV-2 Molecular Testing and Genomic Surveillance Reveal Prolonged Infections, Protracted RNA shedding, and Viral Reinfections.

Authors:  C Paul Morris; Chun Huai Luo; Jaiprasath Sachithanandham; Maggie Li; Matthew Schwartz; David C Gaston; Victoria Gniazdowski; Nicolas Giraldo-Castillo; Adannaya Amadi; Julie M Norton; William F Wright; Eili Y Klein; Andrew Pekosz; Heba H Mostafa
Journal:  Front Cell Infect Microbiol       Date:  2022-04-11       Impact factor: 6.073

4.  Receptor binding domain proteins of SARS-CoV-2 variants produced in Nicotiana benthamiana elicit neutralizing antibodies against variants of concern.

Authors:  Narach Khorattanakulchai; Suwimon Manopwisedjaroen; Kaewta Rattanapisit; Chalisa Panapitakkul; Taratorn Kemthong; Nutchanat Suttisan; Kanjana Srisutthisamphan; Suchinda Malaivijitnond; Arunee Thitithanyanont; Anan Jongkaewwattana; Balamurugan Shanmugaraj; Waranyoo Phoolcharoen
Journal:  J Med Virol       Date:  2022-06-01       Impact factor: 20.693
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.